Sort by
Refine Your Search
-
, Switzerland [map ] Subject Areas: Computer Science / Distributed Systems and Networking , Networking , Networking and distributed systems Appl Deadline: 2026/01/08 11:59PM (posted 2025/11/10, listed until
-
service providers operating in high-demand sectors including offshore wind, oil and gas, but also maritime security, demining (UXO, MCM) and search & rescue. As an ETH Zürich Spin-Off, we are a fast-growing
-
100%, Zurich, fixed-term The Center for Security Studies (CSS) at ETH Zurich is a center of competence for Swiss and international security policy. It offers expertise in research, teaching, and
-
to commercial-grade systems, we are seeking a visionary Lead Architect to drive the design and development of the V2.0 system. This role is critical for establishing technical novelty, securing a new IP portfolio
-
organised individual to support multiple experimental and computational research groups. The successful candidate will contribute to both a collaborative research network and institute-wide activities
-
-phonon coupling elements. With these, dedicated scattering rates can be computed and then used in quantum transport simulations. Down the line, we aim to pre-train a common GNN backbone model capable
-
. Profile Ph.D. in Nuclear Engineering, Physics, Chemical Engineering, or a related field. Experience with computational chemistry and simulation tools. Prior knowledge of nuclear safety, severe accident
-
COMPAS XR framework developed at ETH Zürich. Project background The successful candidate will work at the intersection of computational design, XR, human-computer interaction, and robotic fabrication, with
-
-dimensional biological datasets, developing and maintaining bioinformatics pipelines, and collaborating closely with experimental scientists to translate computational findings into biological insight
-
100%, Basel, fixed-term The highly competitive Bio-Engineering Systems for Therapeutics (BEST) postdoc program, part of the Next-gen Bioengineers initiative, is run jointly by ETH Zurich and Roche